Flunixin meglumine 100mg 100mg | Purity Not Available
Adooq Bioscience
Flunixin meglumine (IC50 = 1 nM) can be used as a drug for animals for the management of intestinal ischaemia, colic, and endotoxemia in horses.
More Information Supplier PageFlunixin meglumine (IC50 = 1 nM) can be used as a drug for animals for the management of intestinal ischaemia, colic, and endotoxemia in horses.
More Information Supplier PagePamidronic acid is a nitrogen containing bisphosphonate, used to prevent osteoporosis. It is also used to strengthen bone in Paget’s disease, to prevent bone loss due to steroid use, and in certain cancers with high propensity to bone, such as multiple myeloma.
More Information Supplier PageEtidronic acid is a bisphosphonate used to strengthen bone, treat osteoporosis, and treat Paget’s disease of bone. An etidronate is a salt of etidronic acid, abbeviated MnHEDP. Etidronate, unlike other bisphosphonates, also prevents bone calcification.
More Information Supplier PageFluocinonide is a potent glucocorticoid steroid used topically as an anti-inflammatory agent for the treatment of skin disorders.
More Information Supplier PageFluocinonide is a potent glucocorticoid steroid used topically as an anti-inflammatory agent for the treatment of skin disorders.
More Information Supplier PageAcemetacin is a glycolic acid ester of indometacin. It is metabolized to indometacin, which then acts as an inhibitor of cyclooxygenase, producing the anti-inflammatory effects.
More Information Supplier PageAcemetacin is a glycolic acid ester of indometacin. It is metabolized to indometacin, which then acts as an inhibitor of cyclooxygenase, producing the anti-inflammatory effects.
More Information Supplier PageMometasone furoate is a glucocorticosteroid used topically to reduce inflammation of the skin or in the airways.
More Information Supplier PageMometasone furoate is a glucocorticosteroid used topically to reduce inflammation of the skin or in the airways.
More Information Supplier PageTiclopidine is an adenosine diphosphate (ADP) receptor inhibitor. It inhibits platelet aggregation by altering the function of platelet membranes by blocking ADP receptors. This prevents the conformational change of glycoprotein IIb/IIIa which allows platelet binding to fibrinogen.
More Information Supplier Page